These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10588333)

  • 21. Antiviral activity and mechanism of action of ganciclovir.
    Matthews T; Boehme R
    Rev Infect Dis; 1988; 10 Suppl 3():S490-4. PubMed ID: 2847285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells.
    Cinatl J; Scholz M; Weber B; Cinatl J; Rabenau H; Markus BH; Encke A; Doerr HW
    Transpl Immunol; 1995 Dec; 3(4):313-20. PubMed ID: 8665150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication.
    Cohen T; Williams JD; Opperman TJ; Sanchez R; Lurain NS; Tortorella D
    J Virol; 2016 Dec; 90(23):10715-10727. PubMed ID: 27654292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selective inhibition of replication of human cytomegalovirus by desferrioxamine in vitro and in vivo (case report)].
    Gümbel H; Cinatl J; Rabenau H; Vogel JU; Doerr HW; Ohrloff C
    Ophthalmologe; 1995 Dec; 92(6):840-3. PubMed ID: 8563434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
    Bolger G; Lapeyre N; Rhéaume M; Kibler P; Bousquet C; Garneau M; Cordingley M
    Antiviral Res; 1999 Dec; 44(3):155-65. PubMed ID: 10651067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus.
    Haagmans BL; Stals FS; van der Meide PH; Bruggeman CA; Horzinek MC; Schijns VE
    J Virol; 1994 Apr; 68(4):2297-304. PubMed ID: 8139014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.
    Yang ZH; Lucia HL; Tolman RL; Colonno RJ; Hsiung GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1563-8. PubMed ID: 2554800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
    Waldman WJ; Knight DA; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
    Transplantation; 1999 Sep; 68(6):814-25. PubMed ID: 10515382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible inhibition of cytomegalovirus replication by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 14(1):7-15. PubMed ID: 6259084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo.
    Weber O; Bender W; Eckenberg P; Goldmann S; Haerter M; Hallenberger S; Henninger K; Reefschläger J; Trappe J; Witt-Laido A; Ruebsamen-Waigmann H
    Antiviral Res; 2001 Mar; 49(3):179-89. PubMed ID: 11428244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.
    Waldman WJ; Knight DA; Blinder L; Shen J; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
    Intervirology; 1999; 42(5-6):412-8. PubMed ID: 10702725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury.
    Zhou YF; Shou M; Harrell RF; Yu ZX; Unger EF; Epstein SE
    Cardiovasc Res; 2000 Mar; 45(4):1019-25. PubMed ID: 10728428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rat cytomegalovirus homologue of parvoviral rep genes, r127, encodes a nuclear protein with single- and double-stranded DNA-binding activity that is dispensable for virus replication.
    van Cleef KWR; Scaf WMA; Maes K; Kaptein SJF; Beuken E; Beisser PS; Stassen FRM; Grauls GELM; Bruggeman CA; Vink C
    J Gen Virol; 2004 Jul; 85(Pt 7):2001-2013. PubMed ID: 15218186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Gümbel HO; Chenot JF; Scholz M; Encke A; Doerr HW
    Antiviral Res; 1995 Aug; 27(4):405-18. PubMed ID: 8540759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection.
    Katzenstein DA; Crane RT; Jordan MC
    J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.